title: Thrombin generation during infusion of tissue-type plasminogen activator.
authors.forename: N
authors.initials: N
authors.lastname: Genser
authors.forename: J
authors.initials: J
authors.lastname: Mair
authors.forename: J
authors.initials: J
authors.lastname: Maier
authors.forename: F
authors.initials: F
authors.lastname: Dienstl
authors.forename: B
authors.initials: B
authors.lastname: Puschendorf
authors.forename: P
authors.initials: P
authors.lastname: Lechleitner
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000990:Antithrombin III / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D000990:Antithrombin III; D013300:Streptokinase; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator